Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 550

1.

Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology.

Koehler P, Mellinghoff SC, Lagrou K, Alanio A, Arenz D, Hoenigl M, Koehler FC, Lass-Flörl C, Meis JF, Richardson M, Cornely OA.

J Antimicrob Chemother. 2019 Feb 15. pii: dkz051. doi: 10.1093/jac/dkz051. [Epub ahead of print]

PMID:
30770712
2.

Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India.

Singh A, Singh PK, de Groot T, Kumar A, Mathur P, Tarai B, Sachdeva N, Upadhyaya G, Sarma S, Meis JF, Chowdhary A.

J Antimicrob Chemother. 2019 Feb 11. doi: 10.1093/jac/dkz029. [Epub ahead of print]

PMID:
30753525
3.

Killing of Candida auris by UV-C: importance of exposure time and distance.

de Groot T, Chowdhary A, Meis JF, Voss A.

Mycoses. 2019 Feb 12. doi: 10.1111/myc.12903. [Epub ahead of print]

PMID:
30748018
4.

A novel diagnosis scoring model to predict invasive pulmonary aspergillosis in the intensive care unit.

Rozaliyani A, Sedono R, Jusuf A, Rumende CM, Aniwidyaningsih W, Burhan E, Prasenohadi P, Handayani D, Yunihastuti E, Siagian FE, Jayusman AM, Rusli A, Sungkar S, Prihartono J, Hagen F, Meis JF, Wahyuningsih R.

Saudi Med J. 2019 Feb;40(2):140-146. doi: 10.15537/smj.2019.2.22940.

5.

High-resolution fingerprinting of Candida parapsilosis isolates suggests persistence and transmission of infections among neonatal intensive care unit patients in Kuwait.

Asadzadeh M, Ahmad S, Al-Sweih N, Hagen F, Meis JF, Khan Z.

Sci Rep. 2019 Feb 4;9(1):1340. doi: 10.1038/s41598-018-37855-2.

6.

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M.

Front Microbiol. 2019 Jan 14;9:3245. doi: 10.3389/fmicb.2018.03245. eCollection 2018.

7.

Candida auris otomycosis in Iran and review of recent literature.

Abastabar M, Haghani I, Ahangarkani F, Rezai MS, Taghizadeh Armaki M, Roodgari S, Kiakojuri K, Al-Hatmi AMS, Meis JF, Badali H.

Mycoses. 2019 Feb;62(2):101-105. doi: 10.1111/myc.12886. Review.

PMID:
30585653
8.

Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management.

Lestrade PPA, Meis JF, Melchers WJG, Verweij PE.

Clin Microbiol Infect. 2018 Dec 21. pii: S1198-743X(18)30780-8. doi: 10.1016/j.cmi.2018.11.027. [Epub ahead of print] Review.

PMID:
30580035
9.

Antifungal Resistance: Specific Focus on Multidrug Resistance in Candida auris and Secondary Azole Resistance in Aspergillus fumigatus.

Arikan-Akdagli S, Ghannoum M, Meis JF.

J Fungi (Basel). 2018 Dec 5;4(4). pii: E129. doi: 10.3390/jof4040129. Review.

10.

An unusual case of gastrointestinal basidiobolomycosis mimicking colon cancer; literature and review.

Mohammadi R, Ansari Chaharsoghi M, Khorvash F, Kaleidari B, Sanei MH, Ahangarkani F, Abtahian Z, Meis JF, Badali H.

J Mycol Med. 2018 Dec 12. pii: S1156-5233(18)30263-4. doi: 10.1016/j.mycmed.2018.11.004. [Epub ahead of print]

PMID:
30553627
11.

Prevalence and diversity of filamentous fungi in the airways of cystic fibrosis patients - A Dutch, multicentre study.

Engel TGP, Slabbers L, de Jong C, Melchers WJG, Hagen F, Verweij PE, Merkus P, Meis JF; Dutch Cystic Fibrosis Fungal Collection Consortium.

J Cyst Fibros. 2018 Dec 1. pii: S1569-1993(18)30939-1. doi: 10.1016/j.jcf.2018.11.012. [Epub ahead of print]

PMID:
30514613
12.

Case report: A fatal case of cryptococcosis in an immunocompetent patient due to Cryptococcus deuterogattii (AFLP6/VGII).

Bauer M, Wickenhauser C, Haak A, Pazaitis N, Siebolts U, Mawrin C, Strauss C, Rickerts V, Stoevesandt D, Cornely OA, Meis JF, Hagen F.

JMM Case Rep. 2018 Oct 23;5(10):e005168. doi: 10.1099/jmmcr.0.005168. eCollection 2018 Oct.

13.

Invasive Infections Due to Trichosporon: Species Distribution, Genotyping, and Antifungal Susceptibilities from a Multicenter Study in China.

Guo LN, Yu SY, Hsueh PR, Al-Hatmi AMS, Meis JF, Hagen F, Xiao M, Wang H, Barresi C, Zhou ML, de Hoog GS, Xu YC.

J Clin Microbiol. 2019 Jan 30;57(2). pii: e01505-18. doi: 10.1128/JCM.01505-18. Print 2019 Feb.

PMID:
30463892
14.

ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait.

Ahmad S, Joseph L, Parker JE, Asadzadeh M, Kelly SL, Meis JF, Khan Z.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01900-18. doi: 10.1128/AAC.01900-18. Print 2019 Feb.

PMID:
30455247
15.
16.

Genotyping of Aspergillus fumigatus in Formalin-Fixed Paraffin-Embedded Tissues and Serum Samples From Patients With Invasive Aspergillosis.

de Groot T, Hagen F, Vreuls W, Verweij PE, Chowdhary A, Meis JF.

Front Cell Infect Microbiol. 2018 Oct 23;8:377. doi: 10.3389/fcimb.2018.00377. eCollection 2018.

17.

Frequency and Geographic Distribution of CARD9 Mutations in Patients With Severe Fungal Infections.

Vaezi A, Fakhim H, Abtahian Z, Khodavaisy S, Geramishoar M, Alizadeh A, Meis JF, Badali H.

Front Microbiol. 2018 Oct 12;9:2434. doi: 10.3389/fmicb.2018.02434. eCollection 2018. Review.

18.

Perspectives on misidentification of Trichophyton interdigitale/Trichophyton mentagrophytes using internal transcribed spacer region sequencing: Urgent need to update the sequence database.

Chowdhary A, Singh A, Singh PK, Khurana A, Meis JF.

Mycoses. 2019 Jan;62(1):11-15. doi: 10.1111/myc.12865. Epub 2018 Nov 15. Review.

PMID:
30367553
19.

Molecular epidemiology of environmental Cryptococcus species isolates based on amplified fragment length polymorphism.

Pakshir K, Fakhim H, Vaezi A, Meis JF, Mahmoodi M, Zomorodian K, Javidnia J, Ansari S, Hagen F, Badali H.

J Mycol Med. 2018 Dec;28(4):599-605. doi: 10.1016/j.mycmed.2018.09.005. Epub 2018 Oct 12.

PMID:
30322827
20.

Candida auris: a global fungal public health threat.

Meis JF, Chowdhary A.

Lancet Infect Dis. 2018 Dec;18(12):1298-1299. doi: 10.1016/S1473-3099(18)30609-1. Epub 2018 Oct 4. No abstract available.

PMID:
30293876
21.

Epidemiology of Aspergillus species causing keratitis in Mexico.

Al-Hatmi AMS, Castro MA, de Hoog GS, Badali H, Alvarado VF, Verweij PE, Meis JF, Zago VV.

Mycoses. 2019 Feb;62(2):144-151. doi: 10.1111/myc.12855. Epub 2018 Oct 14.

PMID:
30256460
22.

Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis.

Abastabar M, Haghani I, Shokohi T, Hedayati MT, Aghili SR, Jedi A, Dadashi S, Shabanzadeh S, Hosseini T, Aslani N, Meis JF, Badali H.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01632-18. doi: 10.1128/AAC.01632-18. Print 2018 Dec.

PMID:
30224524
23.

Comparative genotyping and phenotyping of Aspergillus fumigatus isolates from humans, dogs and the environment.

Valdes ID, van den Berg J, Haagsman A, Escobar N, Meis JF, Hagen F, Haas PJ, Houbraken J, Wösten HAB, de Cock H.

BMC Microbiol. 2018 Sep 17;18(1):118. doi: 10.1186/s12866-018-1244-2.

24.

Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates.

Buil JB, Hagen F, Chowdhary A, Verweij PE, Meis JF.

J Fungi (Basel). 2018 Aug 29;4(3). pii: E103. doi: 10.3390/jof4030103.

25.

Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.

Hoenigl M, Gangneux JP, Segal E, Alanio A, Chakrabarti A, Chen SC, Govender N, Hagen F, Klimko N, Meis JF, Pasqualotto AC, Seidel D, Walsh TJ, Lagrou K, Lass-Flörl C, Cornely OA; European Confederation of Medical Mycology (ECMM).

Mycoses. 2018 Nov;61(11):885-894. doi: 10.1111/myc.12836. Epub 2018 Aug 28.

PMID:
30086186
26.

Epidemiology and aetiologies of cryptococcal meningitis in Africa, 1950-2017: protocol for a systematic review.

Nyazika TK, Tatuene JK, Kenfak-Foguena A, Verweij PE, Meis JF, Robertson VJ, Hagen F.

BMJ Open. 2018 Jul 30;8(7):e020654. doi: 10.1136/bmjopen-2017-020654.

27.

Internal validation of GPS MONODOSE CanAur dtec-qPCR kit following the UNE/EN ISO/IEC 17025:2005 for detection of the emerging yeast Candida auris.

Martínez-Murcia A, Navarro A, Bru G, Chowdhary A, Hagen F, Meis JF.

Mycoses. 2018 Nov;61(11):877-884. doi: 10.1111/myc.12834. Epub 2018 Aug 20.

PMID:
30059175
28.

Adjunctive interferon-γ immunotherapy in a pediatric case of Aspergillus terreus infection.

Assendorp EL, Gresnigt MS, Sprenkeler EGG, Meis JF, Dors N, van der Linden JWM, Henriet SSV.

Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1915-1922. doi: 10.1007/s10096-018-3325-4. Epub 2018 Jul 19.

PMID:
30027379
29.

Production of the Invasive Aspergillosis Biomarker Bis(methylthio)gliotoxin Within the Genus Aspergillus: In Vitro and in Vivo Metabolite Quantification and Genomic Analysis.

Vidal-García M, Redrado S, Domingo MP, Marquina P, Colmenarejo C, Meis JF, Rezusta A, Pardo J, Galvez EM.

Front Microbiol. 2018 Jun 12;9:1246. doi: 10.3389/fmicb.2018.01246. eCollection 2018.

30.

Mycotic Keratitis Caused by Fusarium solani sensu stricto (FSSC5): A Case Series.

Boral H, van Diepeningen A, Erdem E, Yağmur M, de Hoog GS, Ilkit M, Meis JF, Al-Hatmi AMS.

Mycopathologia. 2018 Oct;183(5):835-840. doi: 10.1007/s11046-018-0280-7. Epub 2018 Jun 21.

PMID:
29931660
31.

Candida auris.

Saris K, Meis JF, Voss A.

Curr Opin Infect Dis. 2018 Aug;31(4):334-340. doi: 10.1097/QCO.0000000000000469.

PMID:
29878905
32.

The Contribution of Genetic Variation of Streptococcus pneumoniae to the Clinical Manifestation of Invasive Pneumococcal Disease.

Cremers AJH, Mobegi FM, van der Gaast-de Jongh C, van Weert M, van Opzeeland FJ, Vehkala M, Knol MJ, Bootsma HJ, Välimäki N, Croucher NJ, Meis JF, Bentley S, van Hijum SAFT, Corander J, Zomer AL, Ferwerda G, de Jonge MI.

Clin Infect Dis. 2019 Jan 1;68(1):61-69. doi: 10.1093/cid/ciy417.

PMID:
29788414
33.

Microsatellite genotyping of clinical Candida parapsilosis isolates.

Badali H, Rezaie S, Meis JF, Agha Kuchak Afshari S, Modiri M, Hagen F, Moazeni M, Mohammadi R, Khodavaisy S.

Curr Med Mycol. 2017 Dec;3(4):15-20. doi: 10.29252/cmm.3.4.15.

34.

Airway persistence by the emerging multi-azole-resistant Rasamsonia argillacea complex in cystic fibrosis.

Abdolrasouli A, Bercusson AC, Rhodes JL, Hagen F, Buil JB, Tang AYY, de Boer LL, Shah A, Milburn AJ, Elborn JS, Jones AL, Meis JF, Fisher MC, Schelenz S, Simmonds NJ, Armstrong-James D.

Mycoses. 2018 Apr 27. doi: 10.1111/myc.12789. [Epub ahead of print]

PMID:
29702751
35.

Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany.

Seufert R, Sedlacek L, Kahl B, Hogardt M, Hamprecht A, Haase G, Gunzer F, Haas A, Grauling-Halama S, MacKenzie CR, Essig A, Stehling F, Sutharsan S, Dittmer S, Killengray D, Schmidt D, Eskandarian N, Steinmann E, Buer J, Hagen F, Meis JF, Rath PM, Steinmann J.

J Antimicrob Chemother. 2018 Aug 1;73(8):2047-2053. doi: 10.1093/jac/dky147.

PMID:
29684150
36.

An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital.

Ruiz-Gaitán A, Moret AM, Tasias-Pitarch M, Aleixandre-López AI, Martínez-Morel H, Calabuig E, Salavert-Lletí M, Ramírez P, López-Hontangas JL, Hagen F, Meis JF, Mollar-Maseres J, Pemán J.

Mycoses. 2018 Jul;61(7):498-505. doi: 10.1111/myc.12781. Epub 2018 Jun 8.

PMID:
29655180
37.

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M.

Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018. Erratum in: Front Microbiol. 2019 Jan 14;9:3245.

38.

In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions.

Fakhim H, Vaezi A, Dannaoui E, Sharma C, Mousavi B, Chowdhary A, Meis JF, Badali H.

Diagn Microbiol Infect Dis. 2018 Jul;91(3):266-268. doi: 10.1016/j.diagmicrobio.2018.03.003. Epub 2018 Mar 8.

PMID:
29622284
39.

High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene.

Singh A, Masih A, Khurana A, Singh PK, Gupta M, Hagen F, Meis JF, Chowdhary A.

Mycoses. 2018 Jul;61(7):477-484. doi: 10.1111/myc.12772. Epub 2018 Apr 27.

PMID:
29577447
40.

Post-influenzal triazole-resistant aspergillosis following allogeneic stem cell transplantation.

Talento AF, Dunne K, Murphy N, O'Connell B, Chan G, Joyce EA, Hagen F, Meis JF, Fahy R, Bacon L, Vandenberge E, Rogers TR.

Mycoses. 2018 Aug;61(8):570-575. doi: 10.1111/myc.12770. Epub 2018 Jun 11.

PMID:
29570855
41.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

PMID:
29544767
42.

Triazole resistance surveillance in Aspergillus fumigatus.

Resendiz Sharpe A, Lagrou K, Meis JF, Chowdhary A, Lockhart SR, Verweij PE; ISHAM/ECMM Aspergillus Resistance Surveillance working group.

Med Mycol. 2018 Apr 1;56(suppl_1):83-92. doi: 10.1093/mmy/myx144. Review.

PMID:
29538741
43.

Fusarium metavorans sp. nov.: The frequent opportunist 'FSSC6'.

Al-Hatmi AMS, Ahmed SA, van Diepeningen AD, Drogari-Apiranthitou M, Verweij PE, Meis JF, de Hoog GS.

Med Mycol. 2018 Apr 1;56(suppl_1):144-152. doi: 10.1093/mmy/myx107.

PMID:
29538734
44.

Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species.

Abastabar M, Al-Hatmi AMS, Vafaei Moghaddam M, de Hoog GS, Haghani I, Aghili SR, Shokohi T, Hedayati MT, Daie Ghazvini R, Kachuei R, Rezaei-Matehkolaei A, Makimura K, Meis JF, Badali H.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e00009-18. doi: 10.1128/AAC.00009-18. Print 2018 May.

45.

Molecular characterization and antifungal susceptibility testing of Cryptococcus neoformans sensu stricto from southern Brazil.

Herkert PF, Meis JF, Lucca de Oliveira Salvador G, Rodrigues Gomes R, Aparecida Vicente V, Dominguez Muro M, Lameira Pinheiro R, Lopes Colombo A, Vargas Schwarzbold A, Sakuma de Oliveira C, Simão Ferreira M, Queiroz-Telles F, Hagen F.

J Med Microbiol. 2018 Apr;67(4):560-569. doi: 10.1099/jmm.0.000698. Epub 2018 Feb 20.

PMID:
29461182
46.

Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model.

Fakhim H, Vaezi A, Dannaoui E, Chowdhary A, Nasiry D, Faeli L, Meis JF, Badali H.

Mycoses. 2018 Jun;61(6):377-382. doi: 10.1111/myc.12754. Epub 2018 Mar 14.

PMID:
29460345
47.

Pharmacodynamics of Voriconazole for Invasive Pulmonary Scedosporiosis.

Box H, Negri C, Livermore J, Whalley S, Johnson A, McEntee L, Alastruey-Izquierdo A, Meis JF, Thornton C, Hope W.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02516-17. doi: 10.1128/AAC.02516-17. Print 2018 May.

48.

Development of Echinocandin Resistance in Candida tropicalis following Short-Term Exposure to Caspofungin for Empiric Therapy.

Khan Z, Ahmad S, Mokaddas E, Meis JF, Joseph L, Abdullah A, Vayalil S.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01926-17. doi: 10.1128/AAC.01926-17. Print 2018 Apr.

49.

Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study.

Breda GL, Tuon FF, Meis JF, Herkert PF, Hagen F, de Oliveira LZ, Dias VC, da Cunha CA, Queiroz-Telles F.

Med Mycol. 2018 Jun 1;56(4):406-415. doi: 10.1093/mmy/myx077.

PMID:
29420820
50.

Emergence of azole resistant Aspergillus fumigatus and One Health: time to implement environmental stewardship.

Chowdhary A, Meis JF.

Environ Microbiol. 2018 Apr;20(4):1299-1301. doi: 10.1111/1462-2920.14055. Epub 2018 Feb 23. No abstract available.

PMID:
29393565

Supplemental Content

Support Center